Clinical Trials
5 trialsNCT05430373 2026-04-14
GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors
Grit Biotechnology
Phase 1 Recruiting
NCT05861895 2026-04-07
HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors
HighField Biopharmaceuticals Corporation
Phase 1 Recruiting
NCT06504368 2025-11-06
Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors
Novo Nordisk A/S
Phase 1 Recruiting
NCT06088472 2025-09-29
TIL Injection for the Treatment of Metastatic or Recurrent Solid Tumors
Grit Biotechnology
Phase 1 Recruiting
NCT06897228 2025-03-26
PANK-003 Cell Injection Combined with Standard Adjuvant Chemotherapy After Surgery in Patients with Solid Tumors
Shenzhen Celconta Life Science Co., Ltd.
Phase 1 Recruiting